Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions

被引:0
|
作者
Wan-Qun Chen [1 ]
Feng-Liang Tian [1 ]
Jin-Wei Zhang [2 ]
Xiao-Jun Yang [1 ]
Yan-Ping Li [1 ]
机构
[1] Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine
[2] Department of Dermatology and Cosmetology, Chongqing Hospital of Traditional Chinese Medicine
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
BACKGROUND Spasmolytic polypeptide-expressing metaplasia(SPEM) is a potential preneoplastic lesion.AIM To elucidate the microRNA(miR)-7-mediated preventive and inhibitive effects of Yiwei Xiaoyu granules(YWXY) in SPEM lesions.METHODS Gastric mucosa biopsies were collected from chronic atrophic gastritis patients and healthy people with signed informed consent. YWXY was administered to the mice with induced SPEM by tamoxifen, and the gastric mucosa was harvested on the tenth day of the experiment. Then immunohistochemistry and immunofluorescence were performed to validate the SPEM, lesions and the potential mechanism was investigated. RNA transcripts were detected with reverse transcriptionquantitative polymerase chain reaction.RESULTS The expression of miR-7 was downregulated in the SPEM lesions, and expression of trefoil factor 2(TFF2) and clusterin was high in the human gastric mucosa. In vivo experiments showed that YWXY could inhibit the cell proliferation in the tamoxifen-induced SPEM lesions by regulating Ki67. Simultaneously, YWXY could restore the expression of miR-7 by regulating TFF2 by detection with immunofluorescence but not with reverse transcription-quantitative polymerase chain reaction, indicating its potential mechanism of targeting miR-7 by mediatingTFF2. The expression of vascular endothelial growth factor-β and gastric intrinsic factor was restored within 3 d of YWXY administration for the SPEM lesions, speculating that the possible mechanism of YWXY is to inhibit the development and progression of SPEM by regulating vascular endothelial growth factor-β and gastric intrinsic factor.CONCLUSION mi R-7 downregulation is an early event in SPEM through regulation of TFF2 in human gastric mucosa. YWXY is able to inhibit the cell proliferation and restore the expression of mi R-7 by mediating TFF2 in the SPEM mouse model.
引用
收藏
页码:1741 / 1754
页数:14
相关论文
共 50 条
  • [1] Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions
    Chen, Wan-Qun
    Tian, Feng-Liang
    Zhang, Jin-Wei
    Yang, Xiao-Jun
    Li, Yan-Ping
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1741 - 1754
  • [2] Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression
    Weis, Victoria G.
    Sousa, Josane F.
    LaFleur, Bonnie J.
    Nam, Ki Taek
    Weis, Jared A.
    Finke, Paul E.
    Ameen, Nadia A.
    Fox, James G.
    Goldenring, James R.
    GUT, 2013, 62 (09) : 1270 - 1279
  • [3] Role of spasmolytic polypeptide-expressing metaplasia in gastric mucosal diseases
    Liu, Xi
    Ma, Zhiyuan
    Deng, Zilin
    Yi, Zhiqiang
    Tuo, Biguang
    Li, Taolang
    Liu, Xuemei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (05): : 1667 - 1681
  • [4] INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA
    Sacchi, D.
    Guzzardo, V.
    Guzzinati, S.
    Pizzi, M.
    Fassan, M.
    Cesaro, S.
    Pennelli, G.
    Maddalo, G.
    Albertoni, L.
    Zanco, F.
    Farinati, F.
    Rugge, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S55 - S56
  • [5] INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA
    Sacchi, Diana
    Guzzinati, Stefano
    Pizzi, Marco
    Fassan, Matteo
    Pennelli, Gianmaria
    Maddalo, Gemma
    Albertoni, Laura
    Zanco, Francesca
    Farinati, Fabio
    Rugge, Massimo
    GASTROENTEROLOGY, 2020, 158 (06) : S323 - S323
  • [6] Emerging role of spasmolytic polypeptide-expressing metaplasia in gastric cancer
    Ye, Qiange
    Zhu, Yanmei
    Ma, Yichun
    Wang, Zhangding
    Xu, Guifang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06) : 2673 - 2683
  • [7] Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia
    Lee, Su-Hyung
    Jang, Bogun
    Min, Jimin
    Contreras-Panta, Ela W.
    Presentation, Kimberly S.
    Delgado, Alberto G.
    Piazuelo, M. Blanca
    Choi, Eunyoung
    Goldenring, James R.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 13 (01): : 199 - 217
  • [8] Spasmolytic polypeptide-expressing metaplasia as a marker for gastric cancer risk prediction
    Mozgovoi, S.
    Stepanchenko, M.
    Gubanova, A.
    Parygina, M.
    Fedotova, J.
    Livzan, M.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S105 - S105
  • [9] Macrophages Promote Progression of Spasmolytic Polypeptide-Expressing Metaplasia After Acute Loss of Parietal Cells
    Petersen, Christine P.
    Weis, Victoria G.
    Nam, Ki Taek
    Sousa, Josane F.
    Fingleton, Barbara
    Goldenring, James R.
    GASTROENTEROLOGY, 2014, 146 (07) : 1727 - +
  • [10] Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) Associated with Gastric Cancer in Iceland
    Anna Margrét Halldórsdóttir
    Margrét Sigurdardóttir
    Jón Gunnlaugur Jónasson
    Margrét Oddsdóttir
    Jónas Magnússon
    Jeffrey R. Lee
    James R. Goldenring
    Digestive Diseases and Sciences, 2003, 48 : 431 - 441